Product
LNZ101
Aliases
LNZ101 (Aceclidine /Brimonidine) ophthalmic solution
1 clinical trial
1 indication
Indication
PresbyopiaClinical trial
A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNZ101 and LNZ100 Ophthalmic Solutions in Chinese Healthy Adult Subjects With PresbyopiaStatus: Completed, Estimated PCD: 2024-04-10